Acne scars: what South Korean clinics use, and what the evidence supports

What an acne scar actually is

This decides everything else, and it is where most treatment plans go wrong.

An atrophic acne scar is not discolouration on the surface. It is missing or disorganised tissue in the dermis — a structural defect with a shape. The flat brown or red marks left after a spot are a different thing entirely: post-inflammatory pigmentation, which fades on its own and responds to different treatment.

So the first useful question at a consultation is which of those you have, and in what proportion. Treating pigmentation with a remodelling device, or scarring with a toning laser, is a common and expensive mismatch.

What South Korean clinics offer

Four categories, doing different jobs:

• Microneedle radiofrequency — needles carry energy into the dermis to provoke remodelling.
• Fractional laser — columns of thermal injury through the skin, prompting the same repair.
• Subcision — releasing the fibrous tethers pulling a rolling scar down. A procedure, not a device.
• Filler — lifting an individual depressed scar, which is a temporary correction rather than a structural one.

Most plans combine them, and that is reasonable. What is not reasonable is a package quoted before anyone has looked at what kind of scars you have.

What the evidence supports best

Microneedle radiofrequency has the strongest body of evidence among the options an international patient will be offered.

A 2026 systematic review covering 41 studies and over 1,000 patients found reductions in acne scar scores of 26–100%, with efficacy described as comparable to fractional lasers.

That range is wide and the width is honest: scar types respond differently, devices differ, and settings differ. What it establishes is that the treatment works, not by how much it will work on you.

Why skin type changes the choice

This is the part that matters most for readers in East and Southeast Asia, and it is a better argument than any brand claim.

The same review reports consistent safety across Fitzpatrick skin types, with post-inflammatory hyperpigmentation in 2.9–5% of cases, mild and transient adverse events, and no serious complications across the included trials.

The reason is mechanical. Because the needles deliver energy past the epidermis rather than through it, surface pigment is comparatively spared — which sidesteps the central risk of ablative and high-fluence laser treatment in skin that pigments easily.

When efficacy is comparable and the risk profile is not, the risk profile should decide.

What results are realistic

Improvement, not removal.

The published outcomes are reductions in scar scores. Nobody in the literature reports clearance, and a clinic promising it is making a claim the evidence does not carry. A realistic expectation is that scars become markedly less visible, over a course, with remodelling continuing for months after the last session.

Two practical consequences: judge the result late rather than early, and be sceptical of a package sold with a promised endpoint.

What to ask at a consultation

• Which of my marks are scars and which are pigmentation? Get the answer before the plan.
• What scar types do I have, and how does that change what you are proposing?
• Which device, and what is its Korean product name?
• What needle depth and energy, and why those for my skin type?
• How many sessions, at what interval, and what is the total?
• When should I judge the result?

The bottom line

Atrophic acne scars are a structural problem, so the treatments that help are the ones that remodel the dermis. Microneedle radiofrequency has the best evidence among the common options — 26–100% reduction in scar scores across 41 studies, comparable to fractional lasers — and its consistent safety across skin types is the strongest argument for it in skin that pigments easily. Expect meaningful improvement over a course, not removal.